Talphera, Inc. (TLPH)
NASDAQ: TLPH · Real-Time Price · USD
0.707
+0.077 (12.17%)
Jan 22, 2025, 1:04 PM EST - Market open
Talphera Revenue
Talphera had revenue of $281.00K in the twelve months ending September 30, 2024, down -24.05% year-over-year. In the year 2023, Talphera had annual revenue of $651.00K.
Revenue (ttm)
$281.00K
Revenue Growth
-24.05%
P/S Ratio
53.58
Revenue / Employee
$18,733
Employees
15
Market Cap
12.04M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 87.70B |
Merck & Co. | 63.17B |
AbbVie | 55.53B |
AstraZeneca | 51.21B |
Novartis AG | 49.94B |
Thermo Fisher Scientific | 42.37B |
Abbott Laboratories | 41.22B |
TLPH News
- 8 days ago - Talphera Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT Study - PRNewsWire
- 2 months ago - Talphera, Inc. (TLPH) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate Update - PRNewsWire
- 2 months ago - Talphera to Host Third Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, November 13, 2024 - PRNewsWire
- 3 months ago - Talphera to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual Summit - PRNewsWire
- 4 months ago - Talphera to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - PRNewsWire
- 5 months ago - Talphera Announces First Patient Enrolled in the Registrational Trial Evaluating Nafamostat for Anticoagulation of the Extracorporeal Circuit - PRNewsWire
- 5 months ago - Talphera, Inc. (TLPH) Q2 2024 Earnings Call Transcript - Seeking Alpha